{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:12:15Z","timestamp":1791414735123,"version":"4.3.3"},"reference-count":41,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T00:00:00Z","timestamp":1286755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:p>Real, R., Egido, E., P\u00e9rez, M., Gonz\u00e1lez\u2010Lobato, L., Barrera, B., Prieto, J. G., \u00c1lvarez, A.I., Merino, G. Involvement of breast cancer resistance protein (BCRP\/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin. <jats:italic>J. vet. Pharmacol. Therap.<\/jats:italic><jats:bold>34<\/jats:bold>, 313\u2013321.<\/jats:p><jats:p>Danofloxacin, a veterinary fluoroquinolone antimicrobial drug, is actively secreted into milk by an as yet unknown mechanism. One of the main determinants of active drug secretion into milk is the transporter (BCRP\/ABCG2). The main purpose was to determine whether danofloxacin is an <jats:italic>in vitro<\/jats:italic> substrate for Bcrp1\/BCRP and to assess its involvement in danofloxacin secretion into milk. In addition, the role of potential drug\u2013drug interactions in this process was assessed using ivermectin. Danofloxacin was transported <jats:italic>in vitro<\/jats:italic> by Bcrp1\/BCRP, and ivermectin efficiently blocked this transport. Experiments with Bcrp1<jats:sup>\u2212\/\u2212<\/jats:sup> mice showed no evidence of the involvement of Bcrp1 in plasma pharmacokinetics of danofloxacin. However, the milk concentration and milk\u2010to\u2010plasma ratio of danofloxacin were almost twofold higher in wild\u2010type compared with Bcrp1<jats:sup>\u2212\/\u2212<\/jats:sup> mice. The <jats:italic>in vivo<\/jats:italic> interaction with ivermectin was studied in sheep after co\u2010administration of danofloxacin (1.25\u2003mg\/kg, i.m.) and ivermectin (0.2\u2003mg\/kg, s.c.). Ivermectin had no significant effect on the plasma levels of danofloxacin but significantly decreased danofloxacin concentrations in milk by almost 40%. Concomitant administration of multiple drugs, often used in veterinary therapy, may not only affect their pharmacological activity but also their secretion into milk, because of potential drug\u2013drug interactions mediated by BCRP.<\/jats:p>","DOI":"10.1111\/j.1365-2885.2010.01241.x","type":"journal-article","created":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T03:09:25Z","timestamp":1286852965000},"page":"313-321","source":"Crossref","is-referenced-by-count":65,"title":["Involvement of breast cancer resistance protein (BCRP\/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin"],"prefix":"10.1111","volume":"34","author":[{"given":"R.","family":"REAL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"EGIDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"P\u00c9REZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"GONZ\u00c1LEZ\u2010LOBATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"BARRERA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"PRIETO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"\u00c1LVAREZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"MERINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,11]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen J.D.","year":"2002","journal-title":"Molecular Cancer Therapeutics"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21233"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.014969"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.11.009"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199609000-00005"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2007.00898.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022046"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.11.007"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi176"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01621-06"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.4.806"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22262"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.20.1651"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1186"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2008.06.001"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/rvsc.1999.0361"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2004.02.022"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1996.tb00062.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.010439"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.008219"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022715"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2003.09.004"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9632-1"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.2.344-349.2002"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.07.003"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.073916"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2009.02.009"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2008.01050.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022029908003348"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2006.00744.x"},{"key":"e_1_2_6_34_1","volume-title":"Introducci\u00f3n al HPLC, Aplicaci\u00f3n y Pr\u00e1ctica","author":"Quattrocchi O.A.","year":"1992"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.065201"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90212-7"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706974"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.03.014"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.1998.00137.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-007-9024-5"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018044"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.041616"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2010.01241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.2010.01241.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:41:51Z","timestamp":1697258511000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2010.01241.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1111\/j.1365-2885.2010.01241.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2010.01241.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,11]]}}}